Technology areas: Biotechnology & Pharmaceuticals • Medical Devices & Mechanical Engineering
2 pending office actions • 2 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready • 3 patents granted in the last 365 days
Medtrade Products Limited currently has 3 pending office actions in the Medical Devices & Mechanical Engineering technology area. This activity reflects a focused strategy for protecting medical and mechanical innovations. The 3 pending actions represent the current active front of the company's patent acquisition efforts.
The prosecution is handled by 3 distinct examiners across 3 distinct art units. This 1:1 ratio between actions and examiners indicates that each matter is being reviewed independently. This structure prevents any single examiner or art unit from having a disproportionate impact on the 3 pending matters, requiring a versatile approach to prosecution.
ARBLE, JESSICA R is identified as the busiest examiner, currently managing 1 busiest examiner pending office action. Because this examiner is responsible for only 1 of the 3 total actions, the workload is evenly spread. Success in the Medical Devices & Mechanical Engineering sector for these filings will depend on navigating the unique expectations of 3 different examiners in 3 separate art units.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Double-patenting + other | 1 (50%) |
| Multi-statute (no §101) | 1 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| ARBLE, JESSICA R | 1 | 66.6% | +25.0% |
| PALLAY, MICHAEL B | 1 | 55.8% | +33.8% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18158156 | HAEMOSTATIC MATERIAL | PALLAY, MICHAEL B | 72d overdue |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18158156 | HAEMOSTATIC MATERIAL | PALLAY, MICHAEL B | 72d overdue |
| 18886074 | WOUND DRESSING | ARBLE, JESSICA R | — |
| Art Unit | Apps |
|---|---|
| 3781 | 1 |
| 1617 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18886074 | WOUND DRESSING | ARBLE, JESSICA R | 3781 | §102§103§112DP | Non-Final OA | — | Pending | Sep 16, 2024 |
| 18158156 | HAEMOSTATIC MATERIAL | PALLAY, MICHAEL B | 1617 | §103§112 | Final Rejection | 72d overdue | Pending | Jan 23, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialMedtrade Products Limited has 2 pending office actions as of October 2026, spread across 2 art units and 2 examiners.
Jessica R Arble has the most, with 1 of Medtrade Products Limited's pending office actions.
Mostly Medical Devices & Mechanical Engineering (USPTO Tech Center 3700), based on where its pending office actions are examined.
